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Abstract
The phenolic phytoalexin resveratrol is well known for its health-promoting and anticancer properties. Its potential benefits
are, however, limited due to its low bioavailability. Pterostilbene, a natural dimethoxylated analog of resveratrol, presents
higher anticancer activity than resveratrol. The mechanisms by which this polyphenol acts against cancer cells are, however,
unclear. Here, we show that pterostilbene effectively inhibits cancer cell growth and stimulates apoptosis and
autophagosome accumulation in cancer cells of various origins. However, these mechanisms are not determinant in cell
demise. Pterostilbene promotes cancer cell death via a mechanism involving lysosomal membrane permeabilization.
Different grades of susceptibility were observed among the different cancer cells depending on their lysosomal heat shock
protein 70 (HSP70) content, a known stabilizer of lysosomal membranes. A375 melanoma and A549 lung cancer cells with
low levels of HSP70 showed high susceptibility to pterostilbene, whereas HT29 colon and MCF7 breast cancer cells with
higher levels of HSP70 were more resistant. Inhibition of HSP70 expression increased susceptibility of HT29 colon and MCF7
breast cancer cells to pterostilbene. Our data indicate that lysosomal membrane permeabilization is the main cell death
pathway triggered by pterostilbene.
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Introduction
Polyphenols form an extensive group of natural molecules with
potential benefits for human health, e.g. cardiac protection,
anticancer activities and diabetes control. The mechanisms
underlying their anticancer activity have been extensively studied
and include anti-oxidative, pro-apoptotic, pro-autophagic, DNA
damaging, anti-angiogenic, and immunostimulatory effects. Re-
sveratrol (Res), the most investigated polyphenol, shows a clear
anticancer activity by both apoptotic and nonapoptotic mecha-
nisms [1]. However, its low bioavailability (e.g. a 14.4 minutes
half-life in the rabbit blood circulation after intravenous admin-
istration of 20 mg/kg) strongly limits its in vivo use [2].
Pterostilbene (3,5-dimethoxi-49-hydroxystilbene; Pter) is a natural
analogue of Res found in different plants such as grapes,
blueberries and narra tree [3]. This natural phenolic phytoalexin,
whose half-life in the blood stream is approximately five times
higher than that of Res, displays potent fungicidal activity and
similar or even more potent antitumor activitiy than Res [4].
The main problem in cancer treatment is to remove pools of
cells capable of developing immunogenic, chemotherapeutic, and
radiotherapeutic resistance. Apoptotic evasion represents one of
the major obstacles since many classical antitumor agents trigger
caspase-mediated apoptotic cell death [5]. Accordingly, new
antitumoral strategies based on nonapoptotic mechanisms have
been developed in the last years, and autophagy, lysosomal cell
death and necrosis have emerged as alternative cell death
programs in cancer cells [6–8].
Lysosomal volume and trafficking, as well as the expression of
lysosomal hydrolases, are notoriously altered in transformed cells
[9]. In fact, effective invasive growth and neoangiogenesis depend
on these alterations [10]. Moreover, development of multidrug
resistance has been also linked to the alterations in the endosome-
lysosomal compartment [11]. In this sense, agents targeting
lysosomes may provide means to revert multidrug resistance.
Furthermore, lysosomal membrane permeabilization has recently
emerged as an effective inducer of caspase-dependent and -
independent cell death [12], and several inducers of lysosomal
membrane permeabilization are presently under development as
anti-cancer drugs. For example, siramesine (a piperidine analogue
originally developed as an antidepressant) and BAMLET (a
complex of bovine lactalbumin and oleic acid), can trigger
lysosomal membrane permeabilization and non-apoptotic cell
death even in apoptosis resistant cancer cells [7,13].
Apoptosis and autophagy have been postulated as main cell
death mechanisms induced by Res i.e., [1,14,15]. Nevertheless, the
anticancer mechanisms induced by Pter remain unclear. In
agreement with other studies we show here that Pter induces
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growth arrest and cancer cell death [16]. Although Pter can
activate apoptosis, we show that this pathway is not essential for its
cytotoxic effect. Our results show that Pter induces destabilization
of the lysosomal membranes and release of lysosomal hydrolases
into the cytoplasm, thus leading to the activation of a caspase-
independent lysosomal cell death program.
Materials and Methods
Cell Culture and Treatments
The cell lines were purchased from the American Type Culture
Collection (ATCC). Human melanoma A375, human lung
carcinoma A549, and human colon adenocarcinoma HT29 were
cultured in Dulbecco’s modified Eagle’s medium (DMEM,
Invitrogen), and human breast adenocarcinoma MCF-7 in
RPMI-1640 medium (Invitrogen). The mediums were supple-
mented with 10% heat-inactivated fetal bovine serum (FBS,
Invitrogen), 100 units/ml penicillin (Invitrogen), and 100 ml/ml
streptomycin (Invitrogen). Cells were grown under standard cell
culture conditions (37uC, 5% CO2/95% air atmosphere) at a
density of 20,000 cells/cm2.
Cancer cells were plated and allowed to attach for 24 h. Then
cells were treated with Res (Sigma-Aldrich) or Pter (Green
Molecular) for 24, 48, and/or 72 h.
Cell Growth Analysis and IC50 Determination
Cell growth was analyzed using the Countess Automated Cell
Counter (Invitrogen). To evaluate IC50s in the presence of Pter or
Res we used the Sulphorhodamine B Toxicology Assay Kit
following manufacturer’s instructions (Sigma-Aldrich) and U.S.
NCI recommendations. Briefly, cells were seeded in 96-well plates
(5,000 cells/well) and treated with Pter or Res (Sigma-Aldrich) (0–
200 mM). Forty-eight hours after polyphenols addition cells were
fixed with 10% trichloroacetic acid. Cell viability was determined
by cellular staining with sulforhodamine B (0.4%) in acetic acid
(1%). Viability data were represented in semilog dose-response
curves. The IC50 values were calculated with Prism GraphPad
software, where the IC50 value represents the concentration of the
test item that induces a response halfway between the baseline and
a maximum response.
Flow Cytometric Analyses
Cells were treated with polyphenols for 24 h, washed in
phosphate buffered saline (PBS), trypsinized, collected with cold
PBS, pelleted (1,000 g for 2 minutes), fixed with 70% chilled
ethanol, and kept at 4uC overnight. Then these cells were pelleted
and washed once in PBS before DNA staining with propidium
iodide (Sigma-Aldrich), in the presence of RNase for 15 minutes.
Analysis of apoptotic and necrotic cell death was carried out
according to manufacturer instructions using Annexin V Alexa
Fluor 488 (Invitrogen) and propidium iodide. Briefly, cancer cells
were seeded and, 24 h later, were treated with different
concentrations of Pter or Res. After 48 h in the presence of
polyphenols cells were harvested and washed once in PBS, then
incubated with a solution containing Annexin V Alexa Fluor 488
in a buffer containing propidium iodide.
Lysosomal membrane integrity was evaluated using acridin
orange. In these experiments after Pter treatment (see above) cells
were stained with 2 mg/ml acridine orange (Invitrogen) which was
present in the culture medium for 15 minutes.
The DNA cellular content, cell death analysis and lysosomal
membrane integrity was analyzed with a BD FACSCanto II flow
cytometer (10,000 cell events were collected per sample).
5-Bromo-29-Deoxyuridine Incorporation Assay
Proliferation assays were done using the Roche Cell Prolifer-
ation ELISA BrdU kit according to manufacturer’s instructions.
Cells were plated in 96-well microplates and, 24 h later, treated
with Pter for 4 h. Then, cells were labeled by the addition of BrdU
(10 mM/well) for another 2 h. After that, cells were fixed and
DNA was denatured with FixDenat solution (200 ml for 30
minutes) at room temperature. Finally, antiBrdU-POD solution
was added for 90 minutes. Using a TMB-like substrate, immune
complexes were detected by measuring the absorbance at 370 nm
and 492 nm using a MultiskanH Spectrum (Thermo scientific).
Caspase Activity Assay
Detection of caspase-3/7 activity was performed with the Apo-
One Homogeneous Caspase-3/7 Assay Kit (Promega) according
to manufacturer instructions. The assay was configured for 96 well
plates (5,000 cells/well). Capase-3/7 activities were evaluated 24
and 48 h after polyphenols addition. This assay provides a
profluorescent substrate (Z-DEVD-R110) which is cleaved by
caspase-3/7 activity to generate the fluorescent rhodamine 110.
Fluorescence was measured by a Fluoroskan Ascent FL (Thermo
Labsystems) (excitation at 485 nm; emission at 538 nm).
Protein Extraction and Western Blot Analysis
After experimental treatments cells were rinsed twice with cold
PBS. Then, proteins were extracted from cultured cells by scraping
in ice-cold lysis buffer (CelLyticTM MT Mammalian Tissue Lysis/
Extraction Reagent, Sigma-Aldrich) containing a protease and
phosphatase inhibitors cocktail (Sigma-Aldrich). Equal amounts of
extracted proteins (30 mg/condition) were resolved using a
criterion XT bis-tris 4–12% gel (Bio-rad) and transferred to an
Immun-BlotTM PVDF membrane (Invitrogen). Blots were incu-
bated overnight at 4uC, separately, with the primary antibodies:
Rabbit polyclonal LC3A/B antibody (1:500) (Abcam); rabbit
monoclonal GAPDH antibody (1:1,000) (Cell signaling); rabbit
monoclonal p62 antibody (1:1,000) (Sigma-Aldrich); rabbit
monoclonal HSP70 antibody (1:200) (Enzo Life Science). Blots
were incubated for 1 h at room temperature with the appropriate
peroxidase-conjugated secondary antibody: Anti-rabbit IgG HRP-
linked antibody (1:1,000) (Cell signaling). Blots were visualized
using a chemiluminescence detection kit ECL western blotting
substrate (Pierce, Thermo Scientific) and the signals were captured
using a ChemiDocTM XRS+Imaging System (Bio-Rad). The
density of the bands was measured using Image Lab SoftwareTM
version 2.0.1 (Bio-Rad).
Confocal and Fluorescence Microscopy
A375-, A549-, MCF7-, and HT29-GFP-LC3 cells were seeded
out on coverslips in 24-well plates and allowed to attach for 24 h.
Then cells were treated with Pter (50 mM) for 24 h, or with
Concanamycin A (2 nM) (Sigma-Aldrich) or Rapamycin (100 nM)
(Sigma-Aldrich) for 1 h. Both control and treated cells were fixed
with paraformaldehyde (PFA) 4% for 10 minutes at 4uC. Cells
were washed twice with DPBS (Invitrogen), mounted on
microscope slides with ProLong Gold antifade reagent (Invitro-
gen), and, then, were visualized using a confocal laser microscope
(Leica TCS Sp2).
Lysosomal visualization was carried out after Pter treatment
using the fluorophore Lysotracker Red (Invitrogen). Briefly, cells
were seeded in 6-well cell culture plates. After 24 h of treatment
with Pter cells were stained according to manufacturer recom-
mendations (75 nM, 30 minutes) and imaged with a Nikon
Diaphot inverted microscope.
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Lactate Dehydrogenase Assay
Cytotoxicity induction was determined by measuring lactate
dehydrogenase (LDH) activity released to the extracellular
medium. The LDH release assay was performed using a
citotoxicity detection kitplus (LDH) (Roche Diagnostics) according
to the manufacturer’s instructions. This kit determines spectro-
photometrically the amount of reduced formazan at 490 nm.
This measurement was done with a Multiskan Spectrum
(Thermo scientific). The LDH content of each sample was
calculated according to the following formula: Cytotoxicity
(%) = [(experimental value 2 low control)/(high control 2 low
control)] 6 100.
Cathepsin Activity Assays
Cancer cell lines were seeded in six well-plates (0.26106
cells/well) and, 24 h later, were treated with Pter (0–100 mM).
After removal of the medium, extraction buffer containing
different concentrations of digitonin (Sigma-Aldrich) was used to
separate cytosolic (20 mg/ml) and total (200 mg/ml) cathepsins.
When necessary, the concentration of digitonin was optimized
for different cell types. Cells were incubated with extraction
buffer for 15 minutes at 4uC on a rocking platform. Cysteine
and aspartate cathepsin activities were measured using the
fluorescent substrates z-fr-AFC (AFC=7-Amino-4-trifluoro-
methylcoumarin) (excitation at 405 nm; emission at 510 nm)
(Enzo Life Sciences) and Mca-GKPILFFRLK(Dnp)-DR-NH2
[Mca= (7-methoxycoumarin-4-yl)acetyl; Dnp= dinitrophenyl]
(excitation at 320 nm; emission at 420 nm) (Enzo Life Sciences),
respectively. Pepstatin A (5 mg/ml) (Sigma-Aldrich) and Leu-
peptin (50 mg/ml) (Sigma-Aldrich) were used to inhibit the
activity of aspartyl peptidases and serine-cysteine proteases,
respectively.
Electron Microscopy
Cell monolayers were fixed with 2% glutardaldehyde in 0.1 M
phosphate buffer, pH 7.4, for 30 minutes, and with 2% osmium
tetroxide in water for 1 h. Then, samples were dehydrated with
ethanol and counterstained with uranyl acetate, and finally
embedded in TAAB resin (T002, Taab Laboratories). Cells were
sectioned at 2 mm and stained with toluidine blue. Selected
semithin sections were re-embedded and trimmed for ultrathin
sectioning. Ultrathin sections were stained with lead citrate and
examined in a Jeol JEM-1010 electron microscope.
siRNA Transfection
Cells were transfected with siRNA targeting HSPA1A and
HSPA1B (ON-TARGETplus SMARTpool, Dharmacon Re-
search, USA) at a final concentration of 25 nM per well. As
positive control we used a siRNA against glyceraldehyde
phosphate dehydrogenase (ON TARGETplus GAPDH Control
Pool, Dharmacon Research, USA). To account for the nonse-
quence-specific effects, siControl Non-Targeting Pool from
Dharmacon was used.
MCF7 and HT29 cell lines were seeded on 12-well plates
(75,000 cells/well) one day prior to transfection. DharmaFECT
1 siRNA Transfection Reagent (3 ml) was added to 98 ml of
serum free medium and incubated at room temperature for 5
minutes. Hsp70, negative or positive control siRNA (100 ml)
were added and incubated for another 20 minutes. The
transfection reagent/siRNA complex was mixed with 1 ml of
DMEM with 10% FBS and added to the cells. After siRNA
addition, the cells were incubated at standard culture conditions
(37uC, 5% CO2).
Statistical Analyses
Values are expressed as the mean 6 SD. All experiments were
repeated at least three independent times. Data were analyzed
using the Graph Pad Prism version 5.00. The significance of the
difference between the control and each experimental test
condition was analyzed by Student’s t test or one way ANOVA
followed by a Tukey-test. A value of P,0.05 was considered
significant.
Results
Pterostilbene Shows Higher Anticancer Potential than
Resveratrol
Structural modifications of the Res molecule can increase its in
vivo half-life without causing toxic side-effects in normal tissues
[17]. Treatment of human A375 (melanoma), MCF7 (breast
adenocarcinoma), A549 (lung cancer) and HT29 (colon cancer)
cells with Pter reduced tumor cell number in vitro in a
concentration- and time-dependent manner (Figure 1). IC50s
determined by Sulphorhodamine B showed that the growth
inhibitory effect of Pter was cell type-dependent, being much lower
for HT29 (Pter IC50 = 60,3 mmol/L; Res IC50 = 71,9 mmol/L) and
MCF7 (Pter IC50 = 44,0 mmol/L; Res IC50 = 56,6 mmol/L) cells
than for A375 (Pter IC50 = 14,7 mmol/L; Res IC50 = 25,5 mmol/L)
and A549 (Pter IC50 = 28,6 mmol/L; Res IC50 = 36,2 mmol/L)
cells. Notably, the IC50 values were lower for Pter than for Res in
all cases.
Pterostilbene Induces Cell Cycle Arrest and Blocks DNA
Synthesis
Microscopic analysis (data not shown) and data presented above
clearly showed that Pter induced cell death in all cancer cell lines
studied. In order to test whether the cell death was preceded or
accompanied by a growth arrest, we analyzed the effect of Pter on
cell cycle distribution at the 24 h time point. A375 and A549 cells
showed an arrest in the S phase of the cell cycle after 24 h of
treatment with 20 mM Pter (Figure 2A). A similar S phase arrest
was observed in HT29 cells upon treatment with 75 mM Pter, and
also MCF7 cells treated with 10–20 mM Pter showed a tendency to
arrest in the S phase (Figure 2A). Notably, higher concentration
(75 mM) of Pter significantly reduced the portion of A375 cells in
the S phase suggesting that the cells arrested in the S phase before
succumbing (Figure 2A).
To evaluate the effect of Pter on DNA synthesis we measured the
ability of cells to incorporate BrdU after 4 h incubation with
increasing concentrations of Pter. Akin to earlier reports on Res and
other polyphenols [14,15,18], Pter reduced the BrdU incorporation
in a concentration-dependent fashion in all cell lines.
Cell Death Induction by Pterostilbene is Time- and
Concentration-Dependent
The molecular mechanisms underlying the anticancer effects of
natural polyphenols are poorly defined. Res has been shown to be
a potent inducer of both apoptosis [1,14] and autophagy [1,15], as
well as a carcinogenesis inhibitor [19,20]. However, anticancer
mechanisms of its dimethylated analog, Pter, have not been
extensively analyzed. For this purpose we investigated the ability of
Pter ability to induce apoptosis, autophagy and necrosis.
First, we measured the activity of apoptotic effector caspases 3
and 7 (DEVDase activity) in cancer cells treated with Pter. Pter
induced a significant caspase 3/7 activation in A375 and A549
cells, but not in HT29 and MCF7 cells (Figure 3A). Accordingly,
Pter induced the translocation of annexin V to the cell surface
Anticancer Mechanisms Induced by Pterostilbene
PLOS ONE | www.plosone.org 3 September 2012 | Volume 7 | Issue 9 | e44524
(marker of apoptosis) only in A375 and A549 cells (Figure 3B). To
evaluate the contribution of apoptosis on cell death induction we
used a cell-permeable pan-caspase inhibitor z-VADfmk. Notably,
z-VAD-fmk failed to inhibit the Pter-induced reduction in cell
number (Figure 3C). Positive controls of apoptosis and zVADfmk
inhibition capability are shown in Supporting Information (Figure
S1). These results suggest that caspase-independent mechanisms
may play a role in Pter-induced cytotoxicity.
To investigate the involvement of autophagy in Pter-induced
cytotoxicity, we analyzed the levels of LC3II and P62/
SQSTM1 that should increase and decrease, respectively, upon
autophagy induction [21,22]. Notably, 24 h treatment with Pter
induced a concentration-dependent accumulation of both LC3II
(Figure 4A) and P62 (Figure 4B) proteins in all four cell lines as
analyzed by immunoblotting. Furthermore, confocal and fluo-
rescence microscopy of A375, A549, MCF7, and HT29 cells
Figure 1. Effect of pterostilbene and resveratrol on tumor cell growth in vitro. A375, A549, HT29 and MCF7 cells were incubated for 24, 48
or 72 h with indicated concentrations of Pter or Res. Actual cell number was analyzed using the Countess Automated Cell Counter. Results were
expressed as relative proliferation index 6 SD (n = 4) where control is 100% (*P,0.05).
doi:10.1371/journal.pone.0044524.g001
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expressing a GFP-tagged LC3 revealed a clear increase in the
number of large LC3-positive vesicles upon 24 h treatment with
Pter (Figures 4A bottom, and 4C). Visualization of numerous
large (diameter up to 2 mm) vesicles surrounded by a double
membrane by transmission electron microscopy confirmed that
these vesicles are enlarged autophagosomes (Figure 4C). These
results are suggestive of autophagosome accumulation due to
inhibited autophagic flux [22].
To determine the ability of Pter to induce necrotic cell death, we
investigated the integrity of the plasma membrane by measuring
the release of cytosolic lactate dehydrogenase (LDH) to the culture
supernatant [23]. The LDH release was stimulated in all cell lines
after 24 h treatment with Pter at concentrations$50 mM
(Figure 5A). Akin, flow cytometry analyses with Annexin V-FITC
and propidium iodide showed just a moderate necrosis increase in
A375 and A549 (Figure 5B). Although, LDH release was increased
after 48 and 72 h of Pter treatment (Figure 5A), inhibition of
Figure 2. Effect of pterostilbene on cell cycle distribution and DNA synthesis. A) Tumor cells were seeded in six well-plates and treated
24 h later with indicated concentrations of Pter. After 24 h, cells were fixed and stained with propidium iodide as explained under material and
methods. The DNA content of the cells was analyzed by flow cytometry (10,000 cell events were collected per sample). Representative cell cycle
histograms for Control and Pter-treated cells are shown. Results are expressed as % of total cells 6 SD (n = 3) (*p,0.05 Vs. Control). B) DNA synthesis
was evaluated by BrdU incorporation after 4 h of incubation with Pter followed by 2 h with Pter and 10 mM BrdU.
doi:10.1371/journal.pone.0044524.g002
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necroptosis, a serine–threonine kinase receptor-interacting protein
1 (RIP1) dependent form of necrosis [24], did not affect Pter-
induced cell death (Figure 5 C). Thus indicating that other type of
cell death induction different of apoptosis, autophagy, and necrosis
may be activated by Pter. Positive controls showing the capability
of necrostatin-1 to inhibit necroptotic cell death are shown in
Supporting Information (Figure S2).
Pterostilbene Induces Lysosomal Membrane Alterations
Lysosomal leakage has been described as an inducer of cell
death [7,25], and lysosomal destabilization has been shown to
be a common consequence of microtubule-targeting drugs [26].
Thus, to further elucidate the mechanisms underlying Pter-
induced cancer cell death, we studied its possible effects on
lysosomes. For this purpose we evaluated lysosomal membrane
alterations by different methods. First, lysosomal volume was
assayed using acridine orange staining and flow cytometry 24 h
after exposure to Pter. Acridine orange is a metachromatic
fluorescent cationic dye that emits red light when in high
concentration inside the lysosomes, and green light in the
cytosol and nucleus where it mainly stains DNA and RNA and
is less concentrated than in acidic lysosomes. We evaluated the
red fluorescence as an indicator of lysosomal volume [27].
Significant increases in red fluorescence were observed in all
Figure 3. Pter induces caspase-independent cell death. A) Caspase-3/7 (DEVDase) activities were evaluated 24 and 48 h after addition of Pter.
Results are expressed as a relative index of fluorescence 6 SD (n = 3) when compared with control (100%). The results were statistically analyzed by
ANOVA and contrasted by the Tukey test (*p,0.001; **p,0.01 Vs. Control). B) Induction of apoptosis was assayed by staining with Annexin V. The
total percentage of Annexin V-positive cells was determined by flow cytometry 48 h after treatment with DMSO or with increasing concentrations of
Pter (*p,0.001 Vs. Control). C) Effect of Pter on tumor cell number in the presence of 20 mM pancaspase inhibitor zVAD fmk, which was added 1 h
prior to the addition of 50 mM Pter or vehicle (1.5 ml/ml DMSO). Cell number was analyzed 24 and 48 h later. Results are expressed as relative
proliferation index 6 SD (n = 3) where control is 100%.
doi:10.1371/journal.pone.0044524.g003
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tumor cell lines upon treatment with Pter 50 mM (Figure 6A).
As shown by fluorescence microscopy of cells stained with
lysotracker, Pter induced an increase in the number and/or size
of lysosomes (Figure 6B) We observed that these changes were
higher in A375 and A549 than in HT29 and MCF7 cells
(Figure 6A, B).
Next, we analyzed the release of lysosomal cysteine (B, L and
H) and aspartate (D and E) cathepsins to the cytosol as a
marker of lysosomal membrane permeabilization. Remarkably,
Pter caused a concentration-dependent increase in the cytosolic
cathepsin activities in all four cell lines without affecting the
total cellular activities after 24 h of treatment (Figure 6C, D).
To determine the contribution of cysteine (B, L, and H) and
aspartate (D, and E) cathepsins to cell death, we inhibited the
activity of aspartyl peptidases with pepstatin A, and the serine
cysteine proteases with leupeptin. As shown in Figure 6E Pter
induced the same effect in the presence or absence of these
enzyme inhibitors.
Tumor Resistance to Pterostilbene Correlates with HSP70
Cellular Levels
Heat shock protein 70 (HSP70) is an evolutionary conserved
protein that promotes the survival of stressed cells, where
stabilization of lysosomal membranes is one of the protective
mechanisms [28]. Different studies have shown a relationship
between Res and HSP70 expression, although taking into account
the protector role of the protein, HSP70 levels could regulate the
distinct grade of susceptibility shown by the tumor cell lines. To
characterize the higher resistance of HT29 and MCF7 to Pter
treatment (Figure 1, Figure 2, Figure 3A, B and Figure 4C) we
analyzed the possible involvement of HSP70. As shown in
Figure 7A, Hsp70 levels were found to be higher in HT29 and
MCF7 cells than in A375 and A549. Moreover, siRNA-mediated
Figure 4. Effects of pterostilbene on autophagic flux. Proteins were detected by western blot with LC3A/B (A) or SQSTM1/p62 antibodies
(B). Graphic shows the percentage of induction of eGFP-LC3 punctuation/aggregation in control and Pter (50 mM) conditions after 24 h of
treatment (A). Densitometric analysis of SQSTM1/p62 correlated with GAPDH levels. The ratio in untreated control cells was set to 100% (B).
MCF7-eGFP-LC3 cells were visualized by confocal and transmission electronic microscopy after treatment with 50 mM Pter for 24 h or 100 nM
Rapamycin for 1 h (C).
doi:10.1371/journal.pone.0044524.g004
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reduction of HSP70 in HT29 and MCF7 (Figure 7B) cells resulted
in a marked cell death induction (Figure 7C) and a higher
lysosomal membrane susceptibility to Pter (Figure 7D). Therefore,
HSP70 levels, indeed, correlate with the sensitivity of the tumor
cells to Pter-induced cytotoxicity.
Discussion
Cancer is a genetic and epigenetic disease which is associated
with unlimited replicative potential, reduced dependence on
growth-promoting signals, resistance to growth-inhibitory signal-
ing, evasion of cell death activation, sustained angiogenesis, as well
as the ability for tissue invasion and metastatic spread [5].
Although new therapies may extend patients’ lives for days,
months, or even years, the quality of life added is in most cases
questionable. Thus, the development of therapies that could
improve efficacy without compromising a reasonable quality of
life, are urgently required. It is in this particular sense that natural
polyphenols may offer some hope [29].
Anticancer mechanisms elicited by natural polyphenols have
been extensively studied in the last years. However, reported
effects claimed for polyphenols must be carefully evaluated since
large differences, even controversial, are found depending on
experimentals [29]. Res, one of the most studied polyphenols,
shows the ability to induce apoptosis and autophagy, and has
antiproliferative effects [1,14,15,30,31]. However, its antioxidant
properties may potentially reduce oxidative stress thereby inhib-
iting apoptosis and enhancing cell survival [32]. Although potent
anticancer effects have been shown in cultured cells, potential
inhibition of cancer growth by Res in vivo is strongly limited due to
its low bioavailability [2]. Therefore, it is important to take into
consideration other chemical structures, which may preserve
anticancer properties while having higher bioavailability.
It is in this context that Pter, a natural dimethylated analog of
Res with a longer half-life [29], represent an attractive option. Pter
showed higher anticancer effects than Res in all the tumor cell
lines assayed (Figure 1). Nevertheless, A375 melanoma and A549
lung cancer cells were more susceptible to the anticancer action
than HT29 colon cancer and MCF7 breast cancer cells. Thus
suggesting that, the reduction in tumor cell number induced by
Pter depends on differences in the cell lines assayed.
To assay if pterostilbene shows a preferential effect on cancer
cell lines versus their normal counterparts we used normal human
primary epidermal melanocytes from neonatal foreskin and
epithelial lung cells (BEAS2B). The growth inhibitory effect in
vitro was determined by Sulphorhodamine B and showed that
Pter’s IC50 for melanocytes (Pter IC50 = 52,1 mmol/L) was similar
to that found for breast (MCF7) and colon (HT29) cancer cell lines
(see Results section). Whereas epithelial lung cells showed a much
lower IC50 value (Pter’s IC50 = 1,8 mmol/L), but again similar to
Figure 5. Effect of pterostilbene on necrosis induction. A)
Release of LDH activity to the extracellular medium. Cells were exposed
to Pter for 24, 48 and 72 h. Results are expressed as relative LDH
activities 6 SD (n = 3) where control was set to 100%. B) Propidium
iodide fluorescence was plotted against annexin-V fluorescence 24 h
after treatment. Results are expressed as total percentage of necrotic
cells6 SD (n = 3). C) Effect of Pter on tumor cell number in the presence
of the necroptosis inhibitor 5-(Indol-3-ylmethyl)-(2-thio-3-methyl)hy-
dantoin (Nec-1, Calbiochem). Nec-1 25 mM was added 1 h prior to the
addition of 50 mM Pter. Cell number was analyzed 24 and 48 h later.
Results are expressed as relative proliferation index 6 SD (n = 3) where
control is 100%. The results were statistically analyzed by ANOVA and
contrasted by the Tukey test (***p,0.001; **p,0.01; *p,0.05 Vs.
Control).
doi:10.1371/journal.pone.0044524.g005
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Figure 6. Pterostilbene induces lysosomal membrane permeabilization. A) Flow cytometry analysis of acridine orange staining after 24 h
incubation with indicated concentrations of Pter. Increases in red fluorescence (x-axis), observed in treated cells, indicated changes at the lysosomal
membrane. B) Microscopic images of Lysotracker red-stained cells untreated or treated with indicated concentrations of Pter for 24 h. C) Cytosolic
cysteine cathepsin (zFRase) activity expressed as percentage of total activity (n = 7) was measured 24 h after Pter addition. D) Cytosolic aspartyl
cathepsin activity expressed as percentage of total activity (n = 7) after 24 h of Pter treatment. The results were statistically analyzed by ANOVA and
the Tukey test (*p,0.05; **p,0.01; ***p,0.001 vs. control). E) Cathepsins B and D inhibitors, Leupeptin and Pepstatin A, were added 1 h prior to the
addition of 50 mM Pter. Cell number was analyzed 24 h later.
doi:10.1371/journal.pone.0044524.g006
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Figure 7. HSP70 depletion sensitizes cells to Pter. A) Representative HSP70 and GAPDH (loading control) immunoblots of proteins extracted
from indicated cells. Densitometric analysis of the immunoblots (n = 3) are shown below. B) Inhibition of HSP70 expression by siRNA. Cells were
transfected with HSP70 siRNA or GAPDH SiRNA (positive control). Protein levels were measured by western blotting. C) HT29 and MCF7 cells were
seeded and transfected with HSP70 siRNA 24 h later. Pter was added at 24 h post-transfection. Cell viability was performed by sulforhodamine B
colorimetric assay 48 h later. The number of replicates per experiment was at least six (n = 3). The results were statistically analyzed by ANOVA and
the Tukey test (*p,0.05; ***p,0.001 vs. control). D) Cysteine and aspartyl cathepsins were determined in HT29 and MCF7 cells 72 h post- HSP70
siRNA transfection and 24 h after Pter treatment (n = 6). The results were statistically analyzed by ANOVA and the Tukey test (***p,0.001 vs. Pter
50mM).
doi:10.1371/journal.pone.0044524.g007
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those found for A375 or A549 cells. Nevertheless, this is no
surprise. Different polyphenols, such as e.g. resveratrol, curcumin,
green tea polyphenols, or pterostilbene, have anticancer activity in
vivo but without showing any relevant toxicity for the host at
therapeutic effective doses (e.g. [4,33,34]). Naturally this apparent
biological paradox is intriguing. However it seems obvious that
under in vivo conditions other mechanisms, besides polyphenols
(but related to), play a relevant role. In this sense the tumor
microenvironment is of particular interest. For instance, in a
previous report, we showed that intravenous administration to
mice of pterostilbene and quercetin, two structurally related and
naturally occurring small polyphenols, inhibits in vivo metastatic
growth of highly malignant B16 melanoma F10 (B16–F10) cells
[35].
Pterostilbene and quercetin inhibit bcl-2 expression in
metastatic cells, which sensitizes them to vascular endotheli-
um-induced cytotoxicity [35] (a physiological defense mecha-
nism against metastatic cell invasion [36]). In addition
polyphenols increased endothelial NO synthase expression in
the vascular endothelium, thus favoring endothelial NO-induced
tumor cell cytotoxicity during the process of cancer cell-vascular
endothelium interaction [35]. A complex network of intercellu-
lar signaling mechanisms, as well as intracellular signaling
cascades, may also regulate these interactions within the
metastatic microenvironment [37]. This hypothesis opens a
fantastic array of possibilities which, although far beyond the
scope of a single paper, deserve further research.
Polyphenols like Pter show potent cytostatic effects [38,39].
Although, in our experiments we detected lower DNA synthesis
capability and cell cycle arrest in S phase (Figure 2A, B), as suggested
by others [40], the high reduction in cell number elicited by Pter can
be only understood if cell death mechanisms are activated.
Apoptosis has been previously postulated as the main cell death
program activated by Pter [38,40,41]. However, concentrations
unreachable under in vivo conditions have been usually tested in vitro
($75 mM). We evaluated the possible contribution of apoptotic cell
death by analyzing caspase 3/7 activity and the consequence of
their inhibition on the rate of tumor cell growth. Although, caspases
are clearly activated by Pter in A375 and A549 cells, pre-incubation
with the pancaspase inhibitor zVADfmk was unable to reduce cell
death induction (Figure 3A, C). Moreover, HT-29 and MCF7 cells,
latter of which do not express caspase-3 [42], failed to activate
effector caspases and induce apoptotic caspase-dependent cell death
upon Pter treatment (Figure 3A, B). These results suggest that Pter-
induced cell death may also occur via caspase-independent
mechanism. For this reason we investigated the role of other types
of cell death in Pter-induced cytotoxicity.
Macroautophagy (hereafter referred to as autophagy) is an
essential conserved cellular process by which lysosomes degrade
and recycle damaged organelles and macromolecules and
maintain cellular energy levels under nutrient and growth
factor deficiency [43,44]. Although this process regulates the
cellular energy homeostasis during nutrient limitation, autoph-
agy may also represent an independent mode of programmed
cell death [45,46]. Indeed, autophagy activation has been
proposed as an alternative mechanism of cell death induced by
polyphenols [15,40]. However, contradictory results are pre-
sented in the literature [47]. Our data show that Pter induces
an accumulation of autophagosomes (Figure 4C) as well as the
conversion of cytosolic LC3-I to its lipidated membrane-
associated form LC3-II (Figure 4A). Because LC3-II itself is
degraded by autophagy, the relative amount of LC3 at a single
time point alone, does not necessarily indicate an increase in
autophagic flux [22]. P62/sequestosome 1 is a common
component of protein aggregates being degraded by autophagy
[48], and thus the expression level of this protein serves as a
complementary marker for autophagic flux. Pter induced a clear
accumulation of P62/sequestosome 1 indicating an inhibition of
autophagic flux (Figure 4B).
Microtubules have been suggested to be essential for vesicular
and autophagic traffic and consequently, vincristine treatment
induces an accumulation of autophagosomes [26,49]. This
accumulation is caused by a failure in the fusion of autophago-
somes with lysosomes [50], the increase in autophagosome
formation rate [51], or the combination of the two [49]. LC3-II
and P62/sequestosome 1 accumulation and the increment in
the acidic compartment and lysosomal size suggest that fusion of
autophagosomes and lysosomes is alterated. Indeed, natural
polyphenols and synthetic analogs are able to inhibit tubulin
polymerization acting like anti-mitotic drugs [52]. Lysosomal
size alterations by different treatments have been reported to
correlate with reduced lysosomal stability and sensitization to
non-apoptotic cell death pathways [26,53]. Accordingly, Pter
induced an increase in the size of lysosomes, lysosomal
membrane destabilization (Figure 6A, B) and intraluminal
content release (Figure 6C, D).
Taken together our data show that Pter-induced cytotoxicity was
not primarily the consequence of classic apoptosis, autophagy, or
necrosis. Recently, a lysosomal cell death program has been
presented as an alternative cell death pathway for demising highly
apoptosis-resistant tumor cells [7]. In this sense, we show that Pter
promotes the release of lysosomal cathepsins and other hydrolases
into the cytosol. Although Res has been shown capable to induce
cancer cell death through lysosomal cathepsin D [54] and L [55]
release, in our experiments the inhibition of lysosomal cathepsins by
pharmaceutical protease inhibitors did not delay the death process
(Figure 6E). Therefore, lysosomal membrane permeabilization
could be an epiphenomenon of the death process or alternatively,
the cytotoxic effect induced by the massive release of lysosomal
hydrolases simply cannot be inhibited by blocking the activity of
cathepsins D, E, B, L andH. Due to the numerous proteases present
inside the lysosomes, and the impossibility to inhibit all of them
simultaneously without causing massive alterations in cellular
functions, we analyzed the protective effect of HSP70. Interestingly,
resistance to Pter treatment correlates with cellular HSP70 levels
(Figure 1 and Figure 7A). In fact, inhibition of HSP70 expression
(Figure 7B) increased Pter-induced cytotoxicity (Figure 7C) and
lysosomal cathepsins release (Figure 7D).
Our results demonstrate that tumor cell death induction elicited
by Pter is preferentially mediated through lysosomal membrane
permeabilization and depends on HSP70 levels.
Supporting Information
Figure S1 Positive controls of apoptosis and zVADfmk
inhibition capability. Activation of apoptosis and the ability of
zVADfmk to inhibit the process were determined studying cleaved
PARP (Cell Signaling) by western blot. Cells were treated with
Camptothecin [A375 (50 nM); A549, HT29, andMCF7 (500 nM)]
(A), or Pter (20 mM-50 mM) (B) for 24 and 48 h, in absence or
presence of 20 mM pancaspase inhibitor zVAD fmk, which was
added 1 h prior to the addition. C) Percentage of apoptotic cells
after camptothecin treatment was analyzed by fluorescence
microscopy in absence or presence of zVAD fmk.
(TIF)
Figure S2 Positive controls showing the capability of
necrostatin-1 to inhibit necroptotic cell death. Cells were
treated with TNF-a (50 nM) or TNF-a+zVADfmk (20 mM) in
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presence or absence of 30 mM necrostatin-1 for 48 h to show the
capability of necrostatin-1 to inhibit necroptosis. The amount of
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